AMC Cancer Institute
Why should you receive treatment at AMC Cancer Institute?
In 2006, AMC established Korea’s first multidisciplinary cancer institute, initiating its comprehensive approach to cancer treatment. A multidisciplinary clinic is a medical service where multiple specialists from diverse departments gather to provide customized treatment for a cancer patient from diagnosis to surgery. At AMC Cancer Institute, specialists in diagnostic, surgical, medical, and radiation oncology collaborate to develop individualized care plans for each patient.
The Institute has 17 sub-centers that are disease-specific and provides customized cancer treatment through its Center for Personalized Cancer Medicine.
Cancer Institute has conducted the largest number of cancer surgeries in Korea and has the highest survival rate.
The Outcomes Book of AMC Cancer Institute was prepared to provide an objective measure of the excellence of AMC Cancer Institute’s cancer treatment. It aims to improve the quality of care and establish new standards for treating cancer patients.
Typical indicators and cancer-specific indicators have been developed for the five most prevalent cancer types in South Korea: liver cancer, colorectal cancer, stomach cancer, breast cancer, and lung cancer.
The Outcomes Book also highlights AMC Cancer Institute’s distinctive features, such as multidisciplinary care, bio-resource bank, and NGS genomic testing.
AMC Cancer Institute will regularly disclose and manage cancer-specific indicators, providing the best medical care, and establishing new standards for cancer patient treatment.
17 Sub-Centers
- Liver Cancer Center
- Breast Cancer Center
- Head & Neck Cancer Center
- Brain Tumor Center
- Urologic Cancer Center
- Biliary & Pancreatic Cancer Center
- Skin Cancer Center
- Stomach Cancer Center
- Hematologic Cancer & BMT Center
- Lung Cancer Center
- Esophageal Cancer Center
- Sarcoma & Rare Cancer Center
- Colon Cancer Center
- Gynecologic Cancer Center
- Center for Personalized Cancer Medicine
- CAR T-Cell Therapy Center
- Theranostics Center
Cancer Institute
Treatment Performance (2024)
In 2024, AMC Cancer Institute reaffirmed its position as Korea’s leading cancer center, delivering care to over one million cancer patients for the fifth consecutive year.
With a specialized treatment system dedicated to improving both clinical outcomes and quality of life, the institute was ranked among the world’s top five cancer hospitals by Newsweek in its ‘World’s Best Specialized Hospitals 2025’ ranking.
Achievements
- World’s largest number of gastric cancer cases treated
- World’s largest number of cervical cancer laparoscopic surgeries conducted
- Korea’s largest number of cancer surgeries conducted annually (especially liver cancer, pancreatic and biliary cancer, colon cancer, and breast cancer)
- Korea’s first multidisciplinary cancer center (2006)
- Korea’s first personalized cancer medicine center (2012)
- Korea’s first precision medicine platform (2020)
- Approximately 30% of face-to-face multidisciplinary integrated treatment in Korea (2020)
- 500 cases of esophageal cancer robotic surgery (the most significant number in Asia) (2021)
- Over 1 million cancer patients (2020-2024)
- World’s 7th and Asia’s 1st Training Center for Surface-guided Radiation Therapy (2022)
- Korea’s first Theranostics Center (2023)
Support System of AMC Cancer Institute
- Navigator for New Patients
- Hospice & Palliative Care
- Ward for Fast Work-Up
- Clinical Research Ward
- Cancer Edu-Info Center
- Chemotherapy Infusion Room
- Center for Cancer Data Management